{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:42:38Z","timestamp":1725554558018},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s10620-005-2907-z","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T05:43:54Z","timestamp":1124257434000},"page":"1625-1631","source":"Crossref","is-referenced-by-count":12,"title":["A Comparative Study on Endoscopic Ulcer Healing of Omeprazole Versus Rabeprazole with Respect to CYP2C19 Genotypic Differences"],"prefix":"10.1007","volume":"50","author":[{"given":"Takashi","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Shimozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2907_CR1","first-page":"46","volume":"12","author":"KR DeVault","year":"2001","unstructured":"DeVault KR: Gastroesophageal reflux disease: extraesophageal manifestations and therapy. Semin Gastrointest Dis 12:46\u201351, 2001","journal-title":"Semin Gastrointest Dis"},{"key":"2907_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2036.2001.00985.x","volume":"15","author":"R Jones","year":"2001","unstructured":"Jones R, Bytzer P: Review article: Acid suppression in the management of gastro-oesophageal reflux disease\u2014an appraisal of treatment options in primary care. Aliment Pharmacol Ther 15:765\u2013772, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2907_CR3","doi-asserted-by":"crossref","first-page":"22438","DOI":"10.1074\/jbc.272.36.22438","volume":"272","author":"M Besancon","year":"1997","unstructured":"Besancon M, Simon A, Sachs G, Shin JM: Sites of reaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 272:22438\u201322446, 1997","journal-title":"J Biol Chem"},{"issue":"Suppl 3","key":"2907_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","volume":"13","author":"T Ishizaki","year":"1999","unstructured":"Ishizaki T, Horai Y: Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2014emphasis on rabeprazole. Aliment Pharmacol Ther 13(Suppl 3):27\u201336, 1999","journal-title":"Aliment Pharmacol Ther"},{"key":"2907_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003088-200140060-00003","volume":"40","author":"T Andersson","year":"2001","unstructured":"Andersson T, Hassan-Alin M, Hasselgren G, Rohss K, Weidolf L: Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet 40:411\u2013426, 2001","journal-title":"Clin Pharmacokinet"},{"key":"2907_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1023\/A:1011035007591","volume":"18","author":"T Sakai","year":"2001","unstructured":"Sakai T, Aoyama N, Kita T, Sakaeda T, Nishiguchi K, Nishitora Y, Hohda T, Sirasaka D, Tamura T, Tanigawara Y, Kasuga M, Okumura K: CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. Pharm Res 18:721\u2013727, 2001","journal-title":"Pharm Res"},{"key":"2907_CR7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1046\/j.1365-2036.2001.01108.x","volume":"15","author":"N Shirai","year":"2001","unstructured":"Shirai N, Furuta T, Moriyama Y, Okochi H, Kobayashi K, Takashima M, Xiao F, Kosuge K, Nakagawa K, Hanai H, Chiba K, Ohashi K, Ishizaki T: Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Aliment Pharmacol Ther 15:1929\u20131937, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2907_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2125.1998.t01-1-00702.x","volume":"45","author":"T Andersson","year":"1998","unstructured":"Andersson T, Holmberg J, Rohss K, Walan A: Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. Br J Clin Pharmacol 45:369\u2013375, 1998","journal-title":"Br J Clin Pharmacol"},{"key":"2907_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s002280050307","volume":"52","author":"H Katsuki","year":"1997","unstructured":"Katsuki H, Nakamura C, Arimori K, Fujiyama S, Nakano M: Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects. Eur J Clin Pharmacol 52:391\u2013396, 1997","journal-title":"Eur J Clin Pharmacol"},{"key":"2907_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0009-9236(99)70075-5","volume":"65","author":"T Furuta","year":"1999","unstructured":"Furuta T, Ohashi K, Kosuge K, Zhao X-J, Takashima M, Kimura M, Nishimoto M, Hanai H, Kaneko E, Ishizaki T: CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin Pharmacol Ther 65:552\u2013561,1999","journal-title":"Clin Pharmacol Ther"},{"key":"2907_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1067\/mcp.2001.114231","volume":"69","author":"KS Yu","year":"2001","unstructured":"Yu KS, Yim DS, Cho JY, Park SS, Park JY, Lee KH, Jang IJ, Yi SY, Bae KS, Shin S-G: Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19. Clin Pharmacol Ther 69:266\u2013273, 2001","journal-title":"Clin Pharmacol Ther"},{"key":"2907_CR12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF00541938","volume":"26","author":"A K\u00fcpfer","year":"1984","unstructured":"K\u00fcpfer A, Preisig R: Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol 26:753\u2013759, 1984","journal-title":"Eur J Clin Pharmacol"},{"key":"2907_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0163-7258(89)90047-8","volume":"43","author":"GR Wilkinson","year":"1989","unstructured":"Wilkinson GR, Guengerich FP, Branch RA: Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther 43:53\u201376, 1989","journal-title":"Pharmacol Ther"},{"key":"2907_CR14","first-page":"192","volume":"29","author":"L Bertilsson","year":"1995","unstructured":"Bertilsson L: Geographic\/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 29:192\u2013209, 1995","journal-title":"Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet"},{"key":"2907_CR15","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","volume":"269","author":"SM de Morais","year":"1994","unstructured":"de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA: The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 269:15419\u201315422, 1994","journal-title":"J Biol Chem"},{"key":"2907_CR16","first-page":"594","volume":"46","author":"SM de Morais","year":"1994","unstructured":"de Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 46:594\u2013598, 1994","journal-title":"Mol Pharmacol"},{"key":"2907_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007691-199806000-00001","volume":"20","author":"M Kimura","year":"1998","unstructured":"Kimura M, Ieiri I, Mamiya K, Urae A, Higuchi S: Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit 20:243\u2013247, 1998","journal-title":"Ther Drug Monit"},{"key":"2907_CR18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1046\/j.1365-2036.2002.01348.x","volume":"16","author":"T Saitoh","year":"2002","unstructured":"Saitoh T, Fukushima Y, Otsuka H, Hirakawa J, Mori H, Asano T, Ishikawa T, Katsube T, Ogawa K, Ohkawa S: Effects of rabeprazole, lansoprazole, and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. Aliment Pharmacol Ther 16:1811\u20131817, 2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2907_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(96)90214-3","volume":"60","author":"T Kubota","year":"1996","unstructured":"Kubota T, Chiba K, Ishizaki T: Genotyping of S-mephenytoin 4\u2032-hydroxylation in an extended Japanese population. Clin Pharmacol Ther 60:661\u2013666, 1996","journal-title":"Clin Pharmacol Ther"},{"key":"2907_CR20","unstructured":"About NIH Image. Bethesda, MD: National Institutes of Health. Available at: http:\/\/rsb.info.nih.gov\/nih-image\/"},{"key":"2907_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1378\/chest.126.1.192","volume":"126","author":"Y Nakamura","year":"2004","unstructured":"Nakamura Y, Endo C, Sato M, Sakurada A, Watanabe S, Sakata R, Kondo K: A new technique for endobronchial ultrasonography and comparison of two ultrasonic probes. Chest 126:192\u2013197, 2004","journal-title":"Chest"},{"key":"2907_CR22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007691-199404000-00018","volume":"16","author":"T Ishizaki","year":"1994","unstructured":"Ishizaki T, Sohn DR, Kobayashi K, Chiba K, Lee KH, Shin SG, Anderson T, Regardh CG, Lou YC, Zhang Y, Dahl ML, Bertilsson L: Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals. Ther Drug Monit 16:214\u2013215,1994","journal-title":"Ther Drug Monit"},{"key":"2907_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1985.194","volume":"38","author":"K Nakamura","year":"1985","unstructured":"Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA: Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 38:402\u2013408, 1985","journal-title":"Clin Pharmacol Ther"},{"key":"2907_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1590-8658(02)80102-5","volume":"34","author":"KEL McColl","year":"2002","unstructured":"McColl KEL, Kennerley P: Proton pump inhibitors\u2014differences emerge in hepatic metabolism. Dig Liver Dis 34:461\u2013467, 2002","journal-title":"Dig Liver Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2907-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2907-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T21:56:29Z","timestamp":1626386189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2907-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["2907"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2907-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}